PIERIS PHARMACEUTICALS INC

De la TradeVille.ro wiki
Versiunea din 18 septembrie 2024 20:21, autor: Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei PIERIS PHARMACEUTICALS INC listata cu simbolul US.PIRS ==Descriere companie== Pieris Pharmaceuticals, Inc. (https://www.pieris.com/) is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways. The Company’s lead respiratory Anticalin-based drug candidate, PRS-060/AZD1402, which is antagonizes IL-4R alpha, thereby inhibiting by IL-4 and IL-13, two cytokines, small proteins mediat...)
(dif) ← Versiunea anterioară | Versiunea curentă (dif) | Versiunea următoare → (dif)

Pagina dedicata companiei PIERIS PHARMACEUTICALS INC listata cu simbolul US.PIRS

Descriere companie[edit | ]

Pieris Pharmaceuticals, Inc. (https://www.pieris.com/) is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways. The Company’s lead respiratory Anticalin-based drug candidate, PRS-060/AZD1402, which is antagonizes IL-4R alpha, thereby inhibiting by IL-4 and IL-13, two cytokines, small proteins mediating signaling between cells within the human body, known to be mediators in the inflammatory cascade that drive the pathogenesis of asthma and other inflammatory diseases. The lead IO Anticalin-based drug candidate in its pipeline, cinrebafusp alfa, which is designed to target the immune receptor 4-1BB and the tumor target HER2. Cinrebafusp alfa is a genetic fusion of a variant of an HER2-targeting antibody with an Anticalin protein specific for 4-1BB.

Grafic actiuni companie[edit | ]

Ultimele stiri despre PIERIS PHARMACEUTICALS INC (US.PIRS)[edit | ]